E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/24/2012 in the Prospect News Bank Loan Daily.

Endo repaid $140 million of term loan in fourth quarter of 2011

By Tali David

Minneapolis, Feb. 24 - Endo Pharmaceuticals Holdings Inc. said that during the fourth quarter of 2011 it made payments of about $140 million to reduce the term loan debt associated with its acquisition of American Medical Systems Inc., according to a press release.

For the full year ended Dec. 31, Endo said it made payments of about $290 million to reduce the term loan.

At Dec. 31, the company's debt to adjusted EBITDA ratio is 3.0 times. The company said it believes that it will achieve its objective of reducing its debt to adjusted EBITDA ratio to 2.0 to 2.5 times in 2013.

Endo is a Chadds Ford, Pa.-based specialty health care company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.